about
In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate.Innovative approaches to treat Staphylococcus aureus biofilm-related infections.Taking the Silver Bullet Colloidal Silver Particles for the Topical Treatment of Biofilm-Related Infections.Efficacy of Poly-Lactic-Co-Glycolic Acid Micro- and Nanoparticles of Ciprofloxacin Against Bacterial Biofilms.Mind "De GaPP": in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms.Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in Staphylococcus aureus Small Colony Variants.A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity.Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.Alloiococcus otitidis Forms Multispecies Biofilm with Haemophilus influenzae: Effects on Antibiotic Susceptibility and Growth in Adverse Conditions.Suppression of Staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, UM-C162.Safety and Efficacy of Topical Chitogel- Deferiprone-Gallium Protoporphyrin in Sheep Model.Science in the Eye of the Beer-Holder-How To Put On an Effective Pint of Science: The Adelaide Experience.Quatsomes for the treatment of Staphylococcus aureus biofilmBiofilms and effective porosity of hernia mesh: are they silent assassins?Effect of commercial nasal steroid preparation on bacterial growthPrevention of peridural adhesions in spinal surgery: Assessing safety and efficacy of Chitogel with Deferiprone in a sheep model
P50
Q35136316-6E33AA26-B4FE-4C4E-B56A-74C29CAC6543Q36297101-9B1E2FCF-23C4-4F57-AF4D-85892D6E58C8Q38672933-82124F7A-0331-4096-A98E-611746DA3DD6Q38831816-AEF0894D-A0CB-4CED-930D-93A23DF89C18Q38902883-F02BA1E1-FD4C-4D9E-8CC5-94FE33FDD37AQ40142212-3E3A8B98-CB20-4867-8036-AB3604E3706CQ40257070-CFA97A08-817D-4FA0-9AAF-AD87F3EB2889Q40367515-EEDC056A-D014-4119-BD10-BF9EF2EF722DQ41206292-82F5CDC8-A8A6-46F9-8180-86B990EDF5DFQ49437451-D44E27A5-784C-4A8B-B9C6-ECFDE5AB4FB5Q54941831-1DCA9054-399F-429A-968A-C1681C78CAE9Q55188114-FEE7AB1B-4E0A-4A9A-B6C6-9C024A646A3EQ61970318-CD6D060C-9A27-4CEA-8BA5-06EDEA842BFCQ91049033-48875DC8-84F3-492C-AF07-33BAC3B79952Q91480689-1832B908-81D5-4E2C-9A93-C4D4601A1A91Q92709955-AD11BAC1-2B0A-4978-BBA1-CD99C7EA3B47
P50
description
researcher ORCID ID = 0000-0003-2979-8215
@en
wetenschapper
@nl
name
Katharina Richter
@ast
Katharina Richter
@en
Katharina Richter
@es
Katharina Richter
@nl
type
label
Katharina Richter
@ast
Katharina Richter
@en
Katharina Richter
@es
Katharina Richter
@nl
prefLabel
Katharina Richter
@ast
Katharina Richter
@en
Katharina Richter
@es
Katharina Richter
@nl
P106
P31
P496
0000-0003-2979-8215